OpenEvidence Raises $250M, Doubles Valuation to $12B as AI Medical Platform Serves 40% of US Doctors
Summary
OpenEvidence, the AI medical platform dubbed 'ChatGPT for doctors,' raises $250 million in funding that doubles its valuation to $12 billion as the Miami-based startup now serves 40% of US physicians and generates over $100 million annually through advertising revenue.
Key Points
- OpenEvidence raises $250 million in funding led by Thrive Capital and DST, doubling its valuation to $12 billion from $6 billion in October
- The Miami-based AI startup known as 'ChatGPT for doctors' serves 40% of U.S. physicians and generates over $100 million in annual revenue through advertising
- CEO Daniel Nadler says the company differentiates itself from competitors like OpenAI and Anthropic by training exclusively on medical journals rather than open internet data